ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Regulus Therapeutics Inc

Regulus Therapeutics Inc (RGLS)

3.37
-0.12
(-3.44%)
Closed April 30 3:00PM
3.36
-0.01
(-0.30%)
After Hours: 6:54PM

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -7.37M-7.32M-8.13M-8.3M-8.83M-12.26M-15.21M-13.75M
Pre Tax Income -7.14M-7.01M-7.82M-8.06M-8.47M-11.04M-14.06M-12.79M
Net Income -7.14M-7.01M-7.82M-8.06M-8.47M-11.04M-14.06M-12.79M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -7.37M-7.32M-8.13M-8.3M-8.83M-12.26M-15.21M-13.75M
EBITDA -7.32M-7.27M-8.07M-8.22M-8.75M-12.17M-15.12M-13.66M
Year End December 30 2024 20172018201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 72k72k6.83M10.01M0000
Operating Income -70.13M-46.76M-16.83M-14.16M-27.82M-28.24M-31.11M-50.04M
Pre Tax Income -72.1M-48.65M-18.59M-15.73M-27.81M-28.32M-30.04M-46.36M
Net Income -71.91M-48.71M-18.59M-15.73M-27.81M-28.32M-30.04M-46.36M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.692-5.524-0.885-0.233-0.191-1.682-1.179-0.649
EBIT -70.13M-46.76M-16.83M-14.16M-27.82M-28.24M-31.11M-50.04M
EBITDA -67.61M-44.5M-15.72M-13.51M-27.33M-28.12M-30.88M-49.69M